MLYS insider filings

Mineralys Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-20. Screen MLYS transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 9 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Slingsby Brian Taylor — Director1—1 leg · 104,320 sh · $3,005,303—
Congleton Jon — Chief Executive Officer, Director1—1 leg · 75,000 sh · $1,909,665—
Warren Eric — Chief Commercial Officer2—2 legs · 14,875 sh · $402,3244
Karydas Daphne — Director1—1 leg · 3,000 sh · $85,7402
COATS LONNEL — Director2——2
Peterson Kristine — Director2——2

Recent insider filings — Mineralys Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-10-204Peterson Kristine — DirectorGrant/award (A): 12,400 @ $0 · Grant/award (A): 16,600 (derivative) @ $0EDGAR
2026-10-203Peterson Kristine — DirectorHoldings only — no transactions reportedEDGAR
2026-10-204COATS LONNEL — DirectorGrant/award (A): 12,400 @ $0 · Grant/award (A): 16,600 (derivative) @ $0EDGAR
2026-10-203COATS LONNEL — DirectorHoldings only — no transactions reportedEDGAR
2026-10-024Congleton Jon — Chief Executive Officer, DirectorSale (S): 75,000 @ $25.46EDGAR
2026-09-244Slingsby Brian Taylor — DirectorSale (S): 104,320 @ $28.81EDGAR
2026-09-224Warren Eric — Chief Commercial OfficerOption exercise (M): 7,438 @ $13.24 · Sale (S): 7,438 @ $28.12 · Option exercise (M): 7,438 (derivative) @ $0EDGAR
2026-09-174Karydas Daphne — DirectorOption exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $28.58 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-08-254Warren Eric — Chief Commercial OfficerOption exercise (M): 7,437 @ $13.24 · Sale (S): 7,437 @ $25.98 · Option exercise (M): 7,437 (derivative) @ $0EDGAR
2026-08-124Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $27.09 · Option exercise (M): 2,170 (derivative) @ $0EDGAR
2026-08-124Ferguson James J. III — Chief Medical OfficerGrant/award (A): 102,400 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2026-07-234Warren Eric — Chief Commercial OfficerOption exercise (M): 7,438 @ $13.24 · Sale (S): 7,438 @ $26.87 · Option exercise (M): 7,438 (derivative) @ $0EDGAR
2026-07-204Rodman David Malcom — Chief Medical OfficerOption exercise (M): 416 @ $15.44 · Sale (S): 416 @ $26.53 · Option exercise (M): 416 (derivative) @ $0EDGAR
2026-07-154Rodman David Malcom — Chief Medical OfficerOption exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Option exercise (M): 6,349 @ $1.08 · Sale (S): 14,058 @ $27.58 · Sale (S): 6,349 @ $26.61 · Option exercise (M): 3,542 (derivative) @ $0 · +2 moreEDGAR
2026-07-154Congleton Jon — Chief Executive Officer, DirectorSale (S): 10,700 @ $27.24EDGAR
2026-07-104Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $30.30 · Option exercise (M): 2,171 (derivative) @ $0EDGAR
2026-06-304Warren Eric — Chief Commercial OfficerOption exercise (M): 104,124 @ $13.24 · Sale (S): 104,124 @ $25.90 · Option exercise (M): 104,124 (derivative) @ $0EDGAR
2026-06-304Congleton Jon — Chief Executive Officer, DirectorSale (S): 58,000 @ $25.94 · Sale (S): 17,000 @ $26.82EDGAR
2026-06-174Karydas Daphne — DirectorOption exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-06-174Rodman David Malcom — Chief Medical OfficerOption exercise (M): 3,542 @ $10.20 · Sale (S): 9,890 @ $23.81 · Option exercise (M): 4,167 @ $14.25 · Option exercise (M): 417 @ $15.44 · Sale (S): 4,584 @ $25 · Option exercise (M): 3,542 (derivative) @ $0 · +2 moreEDGAR
2026-06-124Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $25 · Option exercise (M): 6,349 @ $1.08 · Sale (S): 6,349 @ $23.93 · Option exercise (M): 2,170 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0EDGAR
2026-05-194Rodman David Malcom — Chief Medical OfficerOption exercise (M): 417 @ $15.44 · Sale (S): 417 @ $27.55 · Option exercise (M): 417 (derivative) @ $0EDGAR
2026-05-134Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $29.71 · Option exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $29.36 · Option exercise (M): 3,541 @ $10.20 · Option exercise (M): 4,166 @ $14.25 · +5 moreEDGAR
2026-04-214Rodman David Malcom — Chief Medical OfficerOption exercise (M): 416 @ $15.44 · Sale (S): 416 @ $31.33 · Option exercise (M): 416 (derivative) @ $0EDGAR
2026-04-154Rodman David Malcom — Chief Medical OfficerOption exercise (M): 6,349 @ $1.08 · Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 14,058 @ $26.54 · Sale (S): 6,348 @ $27.66 · Option exercise (M): 6,349 (derivative) @ $0 · +2 moreEDGAR
2026-04-154Congleton Jon — Chief Executive Officer, DirectorSale (S): 15,730 @ $26.83EDGAR
2026-04-134Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $27.38 · Option exercise (M): 2,170 (derivative) @ $0EDGAR
2026-04-024Karydas Daphne — DirectorOption exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-04-024Congleton Jon — Chief Executive Officer, DirectorSale (S): 19,364 @ $25.50 · Sale (S): 55,183 @ $26.54 · Sale (S): 453 @ $27.05EDGAR
2026-03-314RA CAPITAL MANAGEMENT, L.P. — Director
RA Capital Healthcare Fund LP — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director
Shah Rajeev M. — Director
Purchase (P): 310,700 @ $23.67 · Purchase (P): 58,300 @ $24.16EDGAR
2026-03-174Rodman David Malcom — Chief Medical OfficerOption exercise (M): 417 @ $15.44 · Sale (S): 417 @ $25.65 · Option exercise (M): 417 (derivative) @ $0EDGAR
2026-03-164Rodman David Malcom — Chief Medical OfficerOption exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $27.37 · Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 10,726 @ $25.91 · Sale (S): 3,079 @ $27.37 · +4 moreEDGAR
2026-03-104Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $26.84 · Option exercise (M): 2,171 (derivative) @ $0EDGAR
2026-02-204Gold Alexander M — DirectorGrant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-204Slingsby Brian Taylor — Director, 10% ownerGrant/award (A): 6,200 @ $0 · Other (J): 6,200 @ $0 · Other (J): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0EDGAR
2026-02-204Karydas Daphne — DirectorGrant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-204DiRocco Derek — DirectorGrant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-204Levy Adam Scott — CFO and SecretaryGrant/award (A): 39,900 @ $0 · Grant/award (A): 53,300 (derivative) @ $0EDGAR
2026-02-204Rodman David Malcom — Chief Medical OfficerGrant/award (A): 38,400 @ $0 · Grant/award (A): 51,300 (derivative) @ $0EDGAR
2026-02-204Congleton Jon — Chief Executive Officer, DirectorGrant/award (A): 140,900 @ $0 · Grant/award (A): 187,900 (derivative) @ $0EDGAR
2026-02-204RA CAPITAL MANAGEMENT, L.P. — Director
RA Capital Healthcare Fund LP — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director
Shah Rajeev M. — Director
Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-204SBLENDORIO GLENN — DirectorGrant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-204AKKARAJU SRINIVAS — Director, 10% ownerGrant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-174Rodman David Malcom — Chief Medical OfficerOption exercise (M): 417 @ $15.44 · Sale (S): 417 @ $27.59 · Option exercise (M): 417 (derivative) @ $0EDGAR
2026-02-134Rodman David Malcom — Chief Medical OfficerOption exercise (M): 6,349 @ $1.08 · Sale (S): 5,828 @ $28.94 · Sale (S): 521 @ $29.64 · Option exercise (M): 3,541 @ $10.20 · Sale (S): 3,541 @ $27.33 · Option exercise (M): 4,166 @ $14.25 · +5 moreEDGAR
2026-02-114Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $30.21 · Option exercise (M): 2,171 (derivative) @ $0EDGAR
2026-01-204Rodman David Malcom — Chief Medical OfficerOption exercise (M): 416 @ $15.44 · Sale (S): 416 @ $32.10 · Option exercise (M): 416 (derivative) @ $0EDGAR
2026-01-154Rodman David Malcom — Chief Medical OfficerOption exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 7,709 @ $32.75 · Sale (S): 11,367 @ $32.61 · Option exercise (M): 3,542 (derivative) @ $0 · Option exercise (M): 4,167 (derivative) @ $0EDGAR
2026-01-134Rodman David Malcom — Chief Medical OfficerOption exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $33.27 · Option exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $32.32 · Option exercise (M): 2,170 (derivative) @ $0 · Option exercise (M): 6,348 (derivative) @ $0EDGAR
2026-01-134Congleton Jon — Chief Executive Officer, DirectorSale (S): 9,119 @ $32.21 · Sale (S): 7,117 @ $33.15EDGAR

Recent 8-K events — Mineralys Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-298-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
EDGAR
2026-10-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EDGAR
2026-06-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-228-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MLYS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs